Inhibikase Therapeutics, Inc. (IKT) Revenue 2020–2024
Inhibikase Therapeutics, Inc. (IKT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2024 · since FY2020: $698,468 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $260,501 | +111.0% |
| FY2022 | $123,440 | -96.0% |
| FY2021 | $3.1M | +343.9% |
| FY2020 | $698,468 | — |
Source: SEC XBRL filings · For reference only · Not investment advice